In his latest effort to lower drug costs, President Donald Trump unveiled Friday “Most Favored Nation” pricing deals with ...
The growth potential of the weight-loss market could explode with advances, notably GLP-1 pills, and broader insurance ...
In an Oval Office announcement, Trump said the drug companies Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Genentech, Gilead, GSK, Merck, Novartis and Sanofi have agreed to "most favored nation" ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results